India Planning To Rejuvenate 5mn Hectares By 2030
In News The Union Environment Minister Prakash Javadekar has pledged that India will rejuvenate 50 lakh hectares (5mn hectares) of degraded land between 2021 and [read more]
Earth’s burning lungs: On Amazon’s rainforest fire
Context: Amazon rainforest has seen a considerable spike in the number of fires in 2019. More than 80000 fires have been recorded in this year [read more]
India Calls For Otter Protection At COP 18 of CITES
In News India along with Nepal and Bangladesh has moved a proposal at the Conference of Parties 18 (CoP 18) of the Convention on International [read more]
RBI Set To Transfer 1.76 lakh Crores To The Government
In News In a significant move that will help the central government to tide over the current economic slowdown, the Reserve Bank of India (RBI) [read more]
Currency capers: On falling rupee
Context: The Indian currency touched 72.06 mark on Monday in a series of continued depreciation for past seven weeks. The depreciation stands at over 4% [read more]
Reversing The Economic Slowdown Through A Slew Of Initiatives
In News The Finance Minister Nirmala Sitaraman has announced a slew of initiatives to reverse the economic slowdown that the country is facing. In-Detail Crediting [read more]
New norms: On regulations for foreign investors
SEBI’s liberalized norms for FPIs will make Indian markets attractive to foreign investors Background: In the union budget, the finance minister levied a higher tax [read more]
The Hindu Editorial Analysis : Something Special
Prime Minister Narendra Modi’s Bhutan visit. PM Modi urged for a greater degree of cooperation between the two nations in the areas of Health, Space [read more]
Unclear doctrine: On ‘No First Use’ nuclear policy
Context: On Saturday, India’s defence minister Rajnath singh tweeted that India’s no first use policy of nuclear weapons is subject to ‘circumstances’. What is the [read more]
Pretomanid – A Promising Drug Against TB
In News The anti-TB drug Pretomanid got the approval of the US’s Food & Drug Administration (FDA). It is only the third anti-TB drug that [read more]